Conference
Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials
Authors
Sargent DJ; Marsoni S; Thibodeau SN; Labianca R; Hamilton SR; Torri V; Monges G; Ribic C; Grothey A; Gallinger S
Volume
26
Pagination
pp. 4008-4008
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2008
DOI
10.1200/jco.2008.26.15_suppl.4008
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X